Michael is a seasoned clinical research professional with a comprehensive understanding of the complexities of the patient clinical trial journey. Over the course of nearly 15 years, he has expertly guided test compounds through various phases of clinical trials, focusing on neurodegenerative, neurodevelopmental, psychiatric, and rare diseases. His invaluable expertise has empowered biotech companies, enabling them to have integrative control over their projects. With a deep-rooted passion for enhancing patients' lives and a proven track record of success, Michael remains dedicated to driving advancements in healthcare while fostering meaningful collaborations between pharma and the community.